Preparation method of benzisothiazole derivatives
A technology for benzisothiazole derivatives and derivatives, which is applied in the field of preparation of benzisothiazole derivatives, can solve the problems that benzisothiazole derivatives have not been reported, and achieve various types, high yields, and easy operation. simple effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Methyl phenyl sulfide (I) (496mg, 4mmol), N, N, N', N'-tetramethylethylenediamine (TMEDA, II) (1.86g, 16mmol), n-BuLi (16mmol) Add n-hexane solution (concentration of n-BuLi(III) n-hexane solution is 1.0M) to anhydrous n-hexane (10mL) successively under nitrogen protection, react at 70°C for 2 hours, cool, filter and dry , to give white powder (lithiummethyl)(2-lithiumphenyl)sulfide (1.36 g, yield = 70%)
[0021] With 1.2M lithium methoxide n-hexane solution, 2.5M n-C 10 h 23 Li n-hexane solution replaces the n-BuLi n-hexane solution of the present embodiment respectively, its lithium methylate or n-C 10 h 23 Li all use 16mmol, other is the same as this embodiment, the white powder (lithium methyl) (2-lithium phenyl) sulfide that prepares, its yield is respectively 69.2% and 71.5%.
[0022] The nitrogen in this example was replaced by helium, and the others were the same as in this example to prepare white powdery (lithium methyl)(2-lithium phenyl) sulfide.
[0023...
Embodiment 2
[0026] Preparation of 3-phenylbenzisothiazole (VI-a):
[0027]
[0028] Add (lithiummethyl)(2-lithiumphenyl)sulfide (96.8mg, 0.2mmol) and benzonitrile (V-a) (82.4mg, 0.8mmol) to the n-hexane solution successively, and react at room temperature for 24h. After the reaction was completed, 5 mL of saturated ammonium chloride solution was added, extracted with dichloromethane (5 mL*3), dried, concentrated, and separated by column to obtain 3-phenylbenzisothiazole (VI-a), a white solid (38.8 mg, 92%). 1 H NMR (400MHz, CDCl 3 )δ8.19(d,J=8.2Hz,1H),8.00(d,J=8.2Hz,1H),7.93–7.84(m,2H),7.63–7.50(m,4H),7.47(dd,J =8.1,1.0Hz,1H). 13 C NMR (101MHz, CDCl 3 )δ164.40, 153.52, 135.23, 133.82, 129.35, 128.83, 128.72, 127.51, 125.02, 124.86, 119.96.
Embodiment 3
[0030] Preparation of 3-(2-methylphenyl)benzisothiazole (VI-b):
[0031]
[0032] (Lithium methyl) (2-lithium phenyl) sulfide (96.8mg, 0.2mmol), 2-methylbenzonitrile (V-b) (93.6mg, 0.8mmol) were successively added to the n-hexane solution, and the mixture was heated at room temperature Under the condition of reaction 24h. After the reaction was completed, 5 mL of saturated ammonium chloride solution was added, extracted with dichloromethane (5 mL*3), dried, concentrated, and separated by column to obtain 3-(2-methylphenyl)benzisothiazole (VI-b ), white solid (30.2 mg, 67%). 1 H NMR (400MHz, CDCl 3 )δ8.00(d,J=8.2Hz,1H),7.76(d,J=8.2Hz,1H),7.55(ddd,J=8.1,7.0,1.0Hz,1H),7.48–7.28(m,5H ),2.27(s,3H). 13 CNMR (101MHz, CDCl 3 )δ165.27, 152.57, 137.29, 135.11, 134.35, 130.79, 129.69, 129.04, 127.50, 125.67, 124.89, 124.78, 119.73, 20.03.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


